| __timestamp | BioCryst Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 612613000000 |
| Thursday, January 1, 2015 | 13047000 | 650773000000 |
| Friday, January 1, 2016 | 11253000 | 619061000000 |
| Sunday, January 1, 2017 | 13933000 | 628106000000 |
| Monday, January 1, 2018 | 29514000 | 717599000000 |
| Tuesday, January 1, 2019 | 37121000 | 964737000000 |
| Wednesday, January 1, 2020 | 67929000 | 875663000000 |
| Friday, January 1, 2021 | 118818000 | 886361000000 |
| Saturday, January 1, 2022 | 159371000 | 997309000000 |
| Sunday, January 1, 2023 | 213894000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Takeda Pharmaceutical Company Limited and BioCryst Pharmaceuticals, Inc. offer a fascinating study in contrasts. Over the past decade, Takeda's SG&A expenses have consistently dwarfed those of BioCryst, with figures reaching over 1 trillion yen in 2023. In contrast, BioCryst's expenses have grown from a modest 7 million yen in 2014 to over 200 million yen in 2023, reflecting a significant increase of nearly 2800%.
While Takeda's expenses are higher, they reflect its expansive global operations. BioCryst, on the other hand, shows a rapid growth trajectory, indicating aggressive expansion and investment in its operations. The data from 2014 to 2023 highlights the strategic differences in cost management between these two companies, offering insights into their operational priorities and market strategies.
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and BioCryst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Bausch Health Companies Inc. and BioCryst Pharmaceuticals, Inc.
Mesoblast Limited and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared